MHM - Diagnostics


Flow better

ClearFlow’s mission is to improve patient outcomes and reduce healthcare costs by developing advanced technologies that support best practices and guidelines to prevent chest tube occlusions. ClearFlow’s PleuraFlow® ACT® system is the only device with FDA 510(k)K clearance indicated for the removal of retained blood and the proactive maintenance of chest tube patency after cardiac surgery.

If you are interested in participating in the DGT2022 Congress in Essen, see the attachment With save the date.
To top
Manfred Hannig
Franz-Beiske-Weg 19
48167 Münster

Medical Devices Vertrieb und Medizinproduktberatung Health Care Management

  • Telefon / Phone
    +49 (0)251 67498282
  • Mobile
    +49(0)171 7721083
  • E-Mail
    This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Fax
    +49(0)251 67498283

Please send us requests for more literature, information, brochures, test orders or quotes by e‐mail, stating your name, organisation, department, telephone number and e‐mail address.